Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

被引:97
|
作者
Tong, Xin [1 ]
Pelling, Jill C.
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
Akt; mTOR; apigenin; cancer; CELL-CYCLE ARREST; CHEMOPREVENTIVE BIOFLAVONOID APIGENIN; CYCLOOXYGENASE-2; COX-2; EXPRESSION; SIGNAL-TRANSDUCTION PATHWAYS; GLUTATHIONE-S-TRANSFERASE; HUMAN PANCREATIC-CANCER; CYTOCHROME-C RELEASE; FLAVONOID APIGENIN; DIETARY FLAVONOIDS; TUMOR-CELLS;
D O I
10.2174/18715206113139990119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [41] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [42] Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells
    Yang, Jiali
    Pi, Cuicui
    Wang, Guanghui
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 699 - 707
  • [43] Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells
    Kang, Sokbom
    Dong, Seung Myung
    Kim, Boh-Ram
    Park, Mi Sun
    Trink, Barry
    Byun, Hyun-Jung
    Rho, Seung Bae
    APOPTOSIS, 2012, 17 (09) : 989 - 997
  • [44] Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
    Carpenter, Richard L.
    Jiang, Bing-Hua
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 252 - 266
  • [45] The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer
    Zhang, Wenyuan
    Zhou, Qing
    Wei, Yunhai
    Da, Miao
    Zhang, Chun
    Zhong, Jing
    Liu, Jin
    Shen, Junjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (07): : 2474 - 2484
  • [46] Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
    Adhami, Vaqar Mustafa
    Syed, Deeba Nadeem
    Khan, Naghma
    Mukhtar, Hasan
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (10) : 1277 - 1281
  • [47] Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
    Morgan, Todd M.
    Koreckij, Theodore D.
    Corey, Eva
    CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 237 - 249
  • [48] Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
    Bang, Jieun
    Jun, Mihyeon
    Lee, Soyun
    Moon, Hyuk
    Ro, Simon Weonsang
    PHARMACEUTICS, 2023, 15 (08)
  • [49] Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
    Reilly, R.
    Mroz, M. S.
    Dempsey, E.
    Wynne, K.
    Keely, S. J.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J. A.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] Targeting the PI3K signaling pathway in cancer therapy
    Bartholomeusz, Chandra
    Gonzalez-Angulo, Ana Maria
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 121 - 130